{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:38:30Z","timestamp":1770136710736,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T00:00:00Z","timestamp":1380412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s10067-013-2385-1","type":"journal-article","created":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T06:27:51Z","timestamp":1380349671000},"page":"119-123","source":"Crossref","is-referenced-by-count":42,"title":["Anti-TNF therapy in patients with HBV infection\u2014analysis of 87 patients with inflammatory arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Hua","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-kai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-ruo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-feng","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-feng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,29]]},"reference":[{"key":"2385_CR1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","volume":"337","author":"WM Lee","year":"1997","unstructured":"Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337:1733\u20131745","journal-title":"N Engl J Med"},{"key":"2385_CR2","first-page":"655","volume":"26","author":"XF Liang","year":"2005","unstructured":"Liang XF, Chen YS, Wang XJ et al (2005) A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Chin J Epidemiol 26:655\u2013658","journal-title":"Chin J Epidemiol"},{"key":"2385_CR3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10067-012-1988-2","volume":"31","author":"J Tan","year":"2012","unstructured":"Tan J, Zhou J, Zhao P et al (2012) Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs. Clin Rheumatol 31:1169\u20131175","journal-title":"Clin Rheumatol"},{"key":"2385_CR4","first-page":"363","volume":"18","author":"MY Mok","year":"2000","unstructured":"Mok MY, Ng WL, Yuen MF et al (2000) Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol 18:363\u2013368","journal-title":"Clin Exp Rheumatol"},{"key":"2385_CR5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3899\/jrheum.081246","volume":"36","author":"S Zingarelli","year":"2009","unstructured":"Zingarelli S, Frassi M, Bazzani C et al (2009) Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: report of 3 cases and review of the literature. J Rheumatol 36:1188\u20131194","journal-title":"J Rheumatol"},{"key":"2385_CR6","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1136\/ard.2010.148783","volume":"70","author":"JL Lan","year":"2011","unstructured":"Lan JL, Chen YM, Hsieh TY et al (2011) Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy. Ann Rheum Dis 70:1719\u20131725","journal-title":"Ann Rheum Dis"},{"key":"2385_CR7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/ard.2009.127233","volume":"69","author":"D Vassilopoulos","year":"2010","unstructured":"Vassilopoulos D, Apostolopoulou A, Hadziyannis E et al (2010) Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection. Ann Rheum Dis 69:1352\u20131355","journal-title":"Ann Rheum Dis"},{"key":"2385_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","volume":"45","author":"AS Lok","year":"2007","unstructured":"Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45:507\u2013539","journal-title":"Hepatology"},{"key":"2385_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jmv.1890470314","volume":"47","author":"Y Kawanishi","year":"1995","unstructured":"Kawanishi Y, Hayashi N, Katayama K et al (1995) Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells. J Med Virol 47:272\u2013277","journal-title":"J Med Virol"},{"key":"2385_CR10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/ard.62.7.686","volume":"62","author":"P Ostuni","year":"2003","unstructured":"Ostuni P, Botsios C, Punzi L et al (2003) Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 62:686\u2013687","journal-title":"Ann Rheum Dis"},{"key":"2385_CR11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MD.0b013e3182380a76","volume":"90","author":"R P\u00e9rez-Alvarez","year":"2011","unstructured":"P\u00e9rez-Alvarez R, D\u00edaz-Lagares C, Garc\u00eda-Hern\u00e1ndez F et al (2011) Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases. Medicine (Baltimore) 90:359\u2013371","journal-title":"Medicine (Baltimore)"},{"key":"2385_CR12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/acr.20209","volume":"62","author":"JG Stine","year":"2010","unstructured":"Stine JG, Khokhar OS, Charalambopoulos J et al (2010) Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res (Hoboken) 62:704\u2013711","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2385_CR13","first-page":"118","volume":"31","author":"YH Lee","year":"2013","unstructured":"Lee YH, Bae SC, Song GG (2013) Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy. Clin Exp Rheumatol 31:118\u2013121","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2385-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:28Z","timestamp":1559120248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,29]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2385"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2385-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,29]]}}}